Advanced Biotherapy Inc. (ADVB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Biotherapy Inc. (ADVB)

ADVB 0.344

-0.3%

Jan 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Stephen Goldfarb	4/17/2006 11:29:06 AM
	of 19

The Company submitted its 10-KSB Annual Report to the SEC. It includes an excellent discussion of the company's treatment methodology and patents. Of particular interest is how targeting overproduction of IFN-gamma is earlier in the immune system cascade than treatments already on the market that target other cytokines. This indicates the possibility, with some demonstrated results, of improved efficacy. The Annual Report can be seen at the SEC website (http://www.sec.gov), and the Pinksheets website(http://www.pinksheets.com). There is also a link to the SEC posting on the company's website (http://www.advancedbiotherapy.com). Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next